A Randomized Study to Evaluate the Efficacy and Safety of Bempedoic Acid 180 + Ezetimibe 10 Fixed-Dose Combination Compared to Ezetimibe and Placebo In Subjects With T2DM and Elevated LDL-Cholesterol
Phase of Trial: Phase II
Latest Information Update: 12 Nov 2018
At a glance
- Drugs Bempedoic acid/ezetimibe (Primary) ; Ezetimibe
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Esperion Therapeutics
- 31 Oct 2018 Planned number of patients changed from 168 to 221.
- 31 Oct 2018 Planned End Date changed from 1 Jan 2019 to 1 May 2019.
- 31 Oct 2018 Planned primary completion date changed from 1 Jan 2019 to 1 May 2019.